LAS VEGAS, Nov. 15, 2017 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces that it has exceeded the October gross revenue projection of $500K from the sale of premium flower
Growth Capitalist (https://growthcapitalist.com/2017/11/gb-sciences-exceeds-its-gross-revenue-projections-for-october-doubles-the-industry-average-yield-per-active-flower-light/)
LAS VEGAS, Nov. 15, 2017 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces that it has exceeded the October gross revenue projection of $500K from the sale of premium flower